.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,952,340

« Back to Dashboard
Patent 5,952,340 protects KYTRIL and is included in one NDA. There have been three Paragraph IV challenges on Kytril.

This patent has twenty-five patent family members in nineteen countries.

Summary for Patent: 5,952,340

Title: Use of granisetron for the treatment of postoperative nausea and vomiting
Abstract:The present invention is directed to a method for the treatment of post-operative nausea and vomiting wherein granisetron is administered to a patient in need thereof.
Inventor(s): Sanger; Gareth John (Sawbridgeworth, GB), Davey; Philip Timothy (Bishop's Stortford, GB), Dott; Christopher Stuart (Reigate, GB)
Assignee: SmithKLine Beecham p.l.c. (Brentford, GB)
Application Number:08/525,521
Patent Claim Types:
see list of patent claims
Use;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 3rd percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Roche
KYTRIL
granisetron hydrochloride
INJECTABLE;INJECTION020239-004Mar 11, 1994DISCNNo5,952,340► subscribe POST OPERATIVE NAUSEA AND VOMITING
Roche
KYTRIL
granisetron hydrochloride
INJECTABLE;INJECTION020239-001Dec 29, 1993DISCNNo5,952,340► subscribe POST OPERATIVE NAUSEA AND VOMITING
Roche
KYTRIL
granisetron hydrochloride
INJECTABLE;INJECTION020239-002Mar 11, 1994DISCNNo5,952,340► subscribe POST OPERATIVE NAUSEA AND VOMITING
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,952,340

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9305593Mar 18, 1993
PCT Information
PCT FiledMarch 15, 1994PCT Application Number:PCT/EP94/00820
PCT Publication Date:September 29, 1994PCT Publication Number: WO94/21257

International Patent Family for Patent: 5,952,340

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)511► subscribe
African Regional IP Organization (ARIPO)9400626► subscribe
Austria230596► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc